DeGette, Speier and Dingell introduce legislation to ensure new technologies are secure with adequate privacy protections in place
WASHINGTON, D.C. – As states across the country explore the possibility of developing and deploying new technologies to help curb the spread of the coronavirus, U.S. Reps. Diana DeGette (D-CO), Jackie Speier (D-CA) and Debbie Dingell (D-MI) introduced legislation today to ensure people’s privacy remains protected.
‘It is clear that CDC is being positioned as a scapegoat for the Administration’s own COVID-19 pandemic response failures.’
Drug maker announced Monday its COVID-19 treatment, remdesivir, will cost $3,210 per patient
Congressional investigators find troubling tactics used to mislead consumers
WASHINGTON, D.C. – U.S. Reps. Diana DeGette (D-CO), Frank Pallone, Jr. (D-NJ) and Anna G. Eshoo (D-CA) – who serve as senior members of the House Energy and Commerce Committee – released the findings of a year-long committee investigation into health insurers’ practice of selling so-called “junk health care plans” that offer consumers no real coverage.
WASHINGTON, D.C. – While coronavirus-related research is now in overdrive, most other research has been slowed down or stopped altogether due to pandemic-induced closures of campuses and laboratories.
Hearing comes as number of cases continues to rise across country
WASHINGTON, D.C. – Dr. Anthony Fauci, FDA Commissioner Stephen Hahn, CDC Director Robert Redfield and Assistant Secretary for Health Brett Giroir will testify before the House Energy and Commerce Committee tomorrow to provide the panel an update on what’s being done to curb the spread of COVID-19 here in the U.S. and what more can be done to protect the public health.
WASHINGTON, D.C. – While the Trump administration has encouraged the use of telemedicine across the health care industry during the pandemic, it has refused to relax rules around medication abortion, a move that experts warn may put both patients and providers at greater risk of contracting the coronavirus.